Avondale Wealth Management Edwards Lifesciences Corp Transaction History

Avondale Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 11, 2022	SELL	$106.37 - $130.68 $25,528 - $31,363	-240 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$57.54 - $76.95 $9,206 - $12,312	160 Added 200.0%	240 $17,000
Q3 2019 Oct 24, 2019	SELL	$61.55 - $75.43 $2,462 - $3,017	-40 Reduced 33.33%	80 $18,000
Q1 2019 Apr 22, 2019	BUY	$47.89 - $64.05 $1,915 - $2,562	40 Added 50.0%	120 $23,000
Q4 2018 Jan 23, 2019	BUY	$46.41 - $56.94 $3,712 - $4,555	80 New	80 $12,000

1,356

468M

2.45M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Avondale Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Avondale Wealth Management with notifications on news.